Upcoming Webinar to Address FDA Inspections of Homeopathic Manufacturing Facilities
MILWAUKIE, Ore. (November 22, 2016) – The American Association of Homeopathic Pharmacists’ (AAHP) newest educational webinar will take place on Thursday, Dec. 1, 2016 at 1:00 p.m. EST and will provide best practices for homeopathic manufacturing facilities, specifically as they relate to U.S. Food and Drug Administration (FDA) inspections. Designed for CEOs and managers responsible…
AAHP Encourages Clear and Open Communication on Teething Medicines Tragedies
In the interest of public safety, the American Association of Homeopathic Pharmacists (AAHP) encourages the U.S. Food and Drug Administration to provide clear and open communication on their ongoing investigation of the safety of homeopathic teething medicine. Representing the manufacturers, distributors and marketers of homeopathic drugs, AAHP secretary Eric Foxman said industry leaders were surprised…
Homeopathic Manufacturers Honor Sen. Barbara Ann Mikulski for Career-Long Support of Complementary Health Care
MILWAUKIE, Ore., Oct. 4, 2016 — Senator Barbara Ann Mikulski (D-Md.) recently received a Legislative Excellence Award from the American Association of Homeopathic Pharmacists (AAHP), the U.S. trade association for the manufacturers of homeopathic medicines. Presented during a special ceremony at the association’s bi-annual conference in Baltimore, Md., the prestigious award recognizes the senator’s support…
Homeopathic Association Works with FDA to Educate Manufacturers
MILWAUKIE, Ore. (July 6, 2016) – The American Association of Homeopathic Pharmacists’ (AAHP) latest educational webinar illustrates the homeopathic industry fostering a relationship with the U.S. Food and Drug Administration (FDA) to ensure the highest quality of safe medicines to retailers, consumers and health practitioners across the U.S. Per the request of AAHP, the agency…
Experts Discuss Advertising of Homeopathic Medicines at FTC Workshop
Washington, D.C., Sept. 22, 2015—Trade association leaders, experts in consumer marketing and regulations, and top physicians came together on Monday, September 21 in Washington, D.C. at “Homeopathic Medicine & Advertising: A Federal Trade Commission (FTC) Workshop.” President of the American Association of Homeopathic Pharmacists (AAHP) Mark Land stated, “We have a remarkable story to share…
Homeopathic Industry Proposes More Broad Use of Disclosures to FTC as the Path Forward
Industry leaders provide perspective on partnership opportunities for Federal Trade Commission Washington, D.C., Sept. 21, 2015— To better help consumers make informed choices, the American Association of Homeopathic Pharmacists (AAHP) proposed strengthening product label and advertising disclosures to the Federal Trade Commission (FTC) today in Washington, D.C. at the agency’s “Homeopathic Medicine & Advertising” workshop.…
Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework
Silver Spring, Md., April 20, 2015—The American Association of Homeopathic Pharmacists (AAHP) today told the U.S. Food and Drug Administration that the agency’s regulatory policy for homeopathic medicines has worked effectively for the last 25 years to protect the public health and provide consumer access to safe homeopathic medicines. AAHP, the industry’s trade association, was…
AAHP Addresses OTC Homeopathic Drug Products for Asthma
The American Association of Homeopathic Pharmacists (AAHP), representing the principal manufacturers and distributors of homeopathic medicines in the United States, said today it fully supports the Food and Drug Administration’s position that consumers should seek the advice of their health care provider if they suspect they or their children are experiencing symptoms of asthma, which…
- « Previous
- 1
- 2
- 3
- 4
- Next »